Sign in
4/A

Changes in Ownership

SpyGlass Pharma, Inc. Filed Acc 0001193125-26-046833

Options or other derivatives

  • Director acquired 3,145,619 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Nielsen Kirk G. Director 2026-02-09 Conversion · Series B Preferred Stock −1,690,230 0 I
Nielsen Kirk G. Director 2026-02-09 Conversion · Series C-1 Preferred Stock −548,067 0 I
Nielsen Kirk G. Director 2026-02-09 Conversion · Series C-2 Preferred Stock −548,067 0 I
Nielsen Kirk G. Director 2026-02-09 Conversion · Series D Preferred Stock −359,255 0 I
Loading xslF345X05/ownership.xml…